Orthofix International | OFIX - Current Liabilities


Orthofix International reported $161.03M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Accuray USD 199.44M 4.83M Dec/2025
AngioDynamics USD 71.96M 3.68M Sep/2025
Artivion USD 92.7M 8.86M Mar/2026
AtriCure USD 73.19M 8.33M Mar/2026
Dexcom USD 2.22B 81.3M Mar/2026
EDAP TMS EUR 31.4M 2.71M Sep/2025
Globus Medical USD 482.46M 16.04M Mar/2026
Inogen USD 64.94M 2.12M Sep/2025
Insulet USD 687.5M 7.4M Mar/2026
Integra LifeSciences USD 346.85M 109.14M Mar/2026
J&J USD 57.72B 3.59B Mar/2026
Medtronic USD 9.5B 440M Dec/2025
Mesa Laboratories USD 54.4M 6.1M Dec/2025
Orthofix International USD 161.03M 9.45M Mar/2026
Plus Therapeutics USD 7.96M 4.36M Mar/2026
Smith & Nephew USD 1.54B 236M Dec/2025
STAAR Surgical USD 60.99M 7.51M Mar/2026
Stryker USD 6.32B 1.48B Mar/2026
Tandem Diabetes Care USD 247.96M 5.24M Mar/2026
Teleflex USD 728.05M 33.98M Mar/2026
Veracyte USD 56.11M 3.82M Mar/2026
Zimmer Biomet Holdings USD 2.86B 280.6M Mar/2026